Skip to main content

Table 2 Number and percentage of del[5q] detected using metaphase cytogenetics, FISH and SNP-A alone or in combination in myeloid malignancies (N = 122)

From: Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide

  MC FISH SNP MC+FISH MC+SNP FISH+SNP MC+FISH+SNP
Number 24 27 25 29 30 31 32
Percentage 20% 22% 21% 24% 25% 25% 26%
  1. MC metaphase cytogenetics; FISH fluorescence in situ hybridization; SNP single nucleotide polymorphism array-based karyotyping.